Giorgia Micucci
Meldola, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI).
Journal: Cancer
Published: October 24, 2024
Germline CSF3R Variant in Chronic Myelomonocytic Leukemia: Linking Genetic Predisposition to Uncommon Hemorrhagic Symptoms.
Journal: International journal of molecular sciences
Published: September 21, 2023
Circulating Endothelial Cell Levels Correlate with Treatment Outcomes of Splanchnic Vein Thrombosis in Patients with Chronic Myeloproliferative Neoplasms.
Journal: Journal of personalized medicine
Published: December 16, 2021
Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" Experience.
Journal: Vascular health and risk management
Published: March 21, 2021
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome.
Journal: Cancer
Published: January 18, 2021
Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study.
Journal: Internal and emergency medicine
Published: November 25, 2020
Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides.
Journal: European journal of dermatology : EJD
Published: December 19, 2015
Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosis.
Journal: Diagnostic pathology
Published: September 30, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026